BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc. ("Cosette") announced that the U.S. Food and Drug Administration (FDA) has approved the Abbreviated New Drug Applications (ANDA) for ...

Participants with recurrent bacterial vaginosis demonstrated a significantly higher treatment response to oral metronidazole than to intravaginal lactic acid gel at 2 weeks, but treatment failure was ...

Actavis and Valeant announced that the FDA has approved Metronidazole 1.3% Vaginal Gel for the treatment of bacterial vaginosis. In April 2013, Actavis acquired the rights to Metronidazole 1.3% from ...

The Food and Drug Administration recently approved Glenmark ’s Metronidazole Vaginal gel 0.75%. [Read more: Glenmark obtains FDA nod for generic Brovana] The medication is the generic of Bausch Health ...

CHICAGO – Application of a new formulation of azelaic acid gel to the face reduces the redness and lesions associated with rosacea better than a commonly used treatment (metronidazole gel), according ...

CINCINNATI--(BUSINESS WIRE)--Prasco Laboratories, a Cincinnati-based pharmaceutical company, announced today it has entered into a distribution and supply agreement with Graceway Pharmaceuticals, LLC.

HAWTHORNE, N.Y., July 18, 2006 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) reported today that it has received approval from the U.S. Food and Drug Administration for its ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Actavis and Valeant Pharmaceuticals International Inc.

Alembic Pharmaceuticals’ joint venture, Aleor Dermaceuticals, has received approval from the Food and Drug Administration for its generic Metrogel Gel (metronidazole gel, 1%). The topical gel is ...

Of all risk factors explored thus far, the majority of epidemiologic studies have identified sexual behaviour as the primary risk factor to the occurrence of BV. The nature of this association remains ...

Background: Bacterial vaginosis (BV), a prevalent infection in women of reproductive age, is associated with increased risk of upper genital tract and sexually transmitted infections, and ...

NEW YORK (AP) -- Actavis Inc. said Wednesday it acquired a bacterial vaginosis gel developed by Valeant Pharmaceuticals International Inc. Actavis said it agreed to pay Valeant $55 million for its ...